Vaccine News and Research

Latest Vaccine News and Research

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Telemedicine boom reduced racial gaps in primary care appointment completion rates

Telemedicine boom reduced racial gaps in primary care appointment completion rates

CDC offers public health recommendations for mask-wearing and safer travel

CDC offers public health recommendations for mask-wearing and safer travel

New genetic markers could improve early detection of drug-resistant tuberculosis

New genetic markers could improve early detection of drug-resistant tuberculosis

Third BNT162b2 dose elicits more durable immune response than second dose

Third BNT162b2 dose elicits more durable immune response than second dose

Comparison of COVID-19 vaccination schemes

Comparison of COVID-19 vaccination schemes

Study investigates the cause of lymphopenia as seen in COVID-19 patients

Study investigates the cause of lymphopenia as seen in COVID-19 patients

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

Benefit from convalescent plasma shown in COVID outpatient trial

Benefit from convalescent plasma shown in COVID outpatient trial

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

Infection with SARS-CoV-2 results in antibodies against common colds

Infection with SARS-CoV-2 results in antibodies against common colds

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

Sweeping, limited, or no powers at all? What’s at stake in the mask mandate appeal

Sweeping, limited, or no powers at all? What’s at stake in the mask mandate appeal

A guide to help you keep up with the omicron subvariants

A guide to help you keep up with the omicron subvariants

Prenatal exposure to SARS-CoV-2 raises risk of neurological disorders in infants

Prenatal exposure to SARS-CoV-2 raises risk of neurological disorders in infants

Influenza and pneumonia vaccinations linked with reduced risk of Alzheimer’s disease

Influenza and pneumonia vaccinations linked with reduced risk of Alzheimer’s disease

Racial and ethnic discrimination in a medical setting linked with COVID-19 vaccine refusal

Racial and ethnic discrimination in a medical setting linked with COVID-19 vaccine refusal

World's first malaria vaccine may be available soon across Sub-Saharan Africa

World's first malaria vaccine may be available soon across Sub-Saharan Africa

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.